SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-19-001008
Filing Date
2019-02-14
Accepted
2019-02-14 08:22:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 TG THERAPEUTICS, INC. p19-0117sc13g.htm SC 13G 61100
  Complete submission text file 0000902664-19-001008.txt   62906
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51051 | Film No.: 19600953
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
venBio Select Advisor LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G